相关实验视频
Updated: Jun 30, 2025
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.5K
转录学和代谢学的整合确定了性结肠炎中异常脂质代谢的生物标志物
Xuexuan Ding1, Fangfang Yan1, Wenjian Wang2
1The First Clinical College, Guangdong Medical University, Zhanjiang 524023, Guangdong, China.
International immunopharmacology
|March 15, 2024
概括
性结肠炎 (UC) 研究确定脂酶A2IIA组 (PLA2G2A) 是一个关键的治疗标. 一个新的脂质代谢得分显示了UC的高诊断效果,氧化脂质如12-HHT作为潜在的生物标志物.
科学领域:
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 全球性结肠炎 (UC) 发病率正在上升,但有效的治疗目标仍然难以捉摸.
- 脂质代谢失调越来越多地与UC病变产生有关.
- 在UC中,对脂质代谢相关基因的高通量数据分析尚未得到充分研究.
研究的目的:
- 通过分析脂质代谢来确定性结肠炎 (UC) 的新疗法目标和诊断生物标志物.
- 研究特定基因和脂质特征在UC发育和进展中的作用.
主要方法:
- 利用四个基因表达总量 (GEO) 数据集,包括357名UC患者,用于生物标志物发现.
- 使用机器学习算法 (LASSO,SVM,RF,Boruta) 来识别核心UC生物标志物.
- 在独立数据集和硫酸盐 (DSS) 诱导的UC小鼠模型中验证的发现;进行LC-MS/MS和OPLS-DA进行代谢分析.
主要成果:
- 脂酶A2IIA组 (PLA2G2A) 被确定为一个重要的UC生物标志物,显示出高的诊断准确性 (AUC0.810-1.000) 和炎症肠道组织的上调.
- PLA2G2A表达与免疫细胞透和疾病严重程度正相关.
- 与单个基因相比,一种新的脂质代谢评分显示出更高的诊断效率 (AUC 0.980-1.000);检测到31种异常氧化脂质,包括12-HHT和DHA.
结论:
- PLA2G2A代表了性结肠炎的关键治疗标.
- 氧化脂质,特别是12-HHT,显示为UC的血清学诊断指标的希望.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
181
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
181
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331